The Bundibugyo strain of Ebola, a catch-all term used for a group of viruses that damage the organs and lead to internal bleeding, continues to spread through several African countries. The latest statistics from the World Health Organization (WHO) indicate at least 1,926 infections and 702 deaths in the Democratic Republic of Congo, South Sudan,
Most Americans who invest do it without ever picking a single stock. They put money into an index fund, usually one that tracks the S&P 500, and let the market do the work. For years, that felt close to a free lunch. Buy the whole market, keep costs near zero, and ride the long climb
Wall Street has always preferred to sell the shovels rather than dig for gold. The house keeps its cut whether the player wins or loses, and the oldest edge in finance is owning the table instead of sitting at it. That instinct built the trading desks, the exchanges, and the fee machines that keep the
For years, Frontier Airlines (ULCC) chased Spirit Airlines. Frontier tried to buy Spirit in 2022, lost toJetBlue, then circled back for a second attempt that also fell apart. Now Frontier can get the prize without the purchase. Spirit ceased all operations on May 2, 2026, ending a 33-year run as America’s original ultra-low-cost carrier. Spirit’s
Someone on X (the former Twitter) was criticizing the deal Anthropic struck with SpaceX to use its Colossus data centers. The argument was that handing $45 billion to SpaceX through May 2029 could be a massive unforced error, potentially letting xAI drain Anthropic’s token traffic and leaving Claude as a niche product for premium tasks.
PepsiCo spent February cutting prices. Lay’s, Doritos, Cheetos, and Tostitos are all down 15%. The company needed American shoppers to start buying snacks again, and cheaper prices seemed like the obvious way to get them back. It didn’t really work. And when CEO Ramon Laguarta got on the Q2 earnings call on July 9, he
A single failed trial can undo years of work in one trading session, and Ionis Pharmaceuticals (IONS) just went through both consecutively. Ionis Pharmaceuticals lost nearly a quarter of its value on July 9 after its heart drug Wainua failed to meet the primary goal of a late-stage trial. The next day brought a second
Tesla investors who have bet on Elon Musk and his electric vehicle company have been rewarded for their faith time and again. The stock seems immune to prolonged downturns, even when Tesla (TSLA) fails to deliver on one of Musk’s grandiose promises. And when he does deliver, the stock also pushes higher. But one of
I have been tracking SanDisk’s numbers. It’s one of my favourites. Why? Its performance, and the reason behind the big numbers. And the numbers keep doing something unusual for sure. They keep getting bigger than the already-big numbers that preceded them. If you didn’t know, SanDisk (SNDK) is the top-performing S&P 500 stock in 2026,
Investors came into July expecting a familiar stock market setup leaning on resilient earnings and AI spending, along with a seasonal stretch favoring equities. Though Morgan Stanley doesn’t feel that setup has gone away, it warns of a much narrower margin for error. There’s a major $1.2 trillion question hanging over Big Tech’s AI buildout.